David Apelian

2014 - Achillion Pharmaceuticals

In 2014, David Apelian earned a total compensation of $2.5M as Executive Vice President and Chief Medical Officer at Achillion Pharmaceuticals, a 15% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$212,212
Option Awards$1,791,457
Salary$457,600
Other$32,016
Total$2,493,285

Apelian received $1.8M in option awards, accounting for 72% of the total pay in 2014.

Apelian also received $212.2K in non-equity incentive plan, $457.6K in salary and $32K in other compensation.

Rankings

In 2014, David Apelian's compensation ranked 3,651st out of 13,032 executives tracked by ExecPay. In other words, Apelian earned more than 72.0% of executives.

ClassificationRankingPercentile
All
3,651
out of 13,032
72nd
Division
Manufacturing
1,289
out of 4,965
74th
Major group
Chemicals And Allied Products
419
out of 1,690
75th
Industry group
Drugs
324
out of 1,369
76th
Industry
Pharmaceutical Preparations
262
out of 1,042
75th
Source: SEC filing on April 17, 2017.

Apelian's colleagues

We found four more compensation records of executives who worked with David Apelian at Achillion Pharmaceuticals in 2014.

2014

Milind Deshpande

Achillion Pharmaceuticals

Chief Executive Officer

2014

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2014

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

2014

Gautam Shah

Achillion Pharmaceuticals

Former Executive Vice President and Chief Compliance Officer

News

In-depth

You may also like